Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10780131
Ameliorating nervous systems disorders
granted -
US 10780155
Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, Streptococcus vaccines, and methods for making and using them
granted -
US 10780095
Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists
granted -
US 10774121
Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory
granted -
US 10774344
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10772828
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
granted -
US 10772333
Mollusk-killing biopesticide
granted -
US 10772861
Administration of serine protease inhibitors to the stomach
granted -
US 10774118
Peptides having reduced toxicity that stimulate cholesterol efflux
granted -
US 10774390
Methods and compositions for modulating PrfA mediated virulence gene activation in Listeria spp
granted -
US 10772504
Apparatus, systems and methods for intraoperative imaging
granted -
US 10766908
Calcium L-lactate frameworks as naturally degradable carriers
granted -
US 10766927
Peptides that stimulate subcutaneous adipogenesis
granted -
US 10765636
Mesoporous silica nanoparticles with a lipid bilayer coating for cargo delivery
granted -
US 10765759
Methods of treating an ocular disease or disorder
granted -
US 10758511
Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase
granted -
US 10758496
Estrogen receptor ligand treatment for neurodegenerative diseases
granted -
US 10760048
In vitro production of medial ganglionic eminence precursor cells
granted -
US 10758513
Modulators of mitochondrial protein import
granted -
US 10758632
NIR-conjugated tumor-specific antibodies and uses thereof
granted -
US 10751533
Regulation of autonomic control of bladder voiding after a complete spinal cord injury
granted -
US 10751281
Auris formulations for treating otic diseases and conditions
granted -
US 10752920
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10752581
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
granted